Related content

The negative-balance isolated pelvic perfusion method using ultrahigh-dose cisplatin for invasive bladder cancer with poor risk

By Kimata Ryoji   Kondo Yukihiro   Nemoto Kaoru   Murata Satoru   Kumazaki Tatsuo  

International Journal of Clinical Oncology, Vol. 15, Iss. 5, 2010-10 ,pp. : 433-439

Springer Publishing Company

Access to resources Recommend Favorite

Large volume loading to prevent cisplatin-induced nephrotoxicity during negative-balance isolated pelvic perfusion

By Nakazato Keiko   Kim Chol   Terajima Katsuyuki   Murata Satoru   Fujitani Hitoshi   Nakanishi Kazuhiro   Tajima Hiroyuki   Kumazaki Tatsuo   Sakamoto Atsuhiro  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 10, 2007-10 ,pp. : 741-747

Springer Publishing Company

Access to resources Recommend Favorite

Systemic administration of bevacizumab prolongs survival in an in vivo model of platinum pre-treated ovarian cancer

By                    

Oncology Letters, Vol. 3, Iss. 3, 2012-01 ,pp. : 530-534

Spandidos Publications

Access to resources Recommend Favorite

Effects of renal pelvic high-pressure perfusion on nephrons in a porcine pyonephrosis model

By              

Experimental and Therapeutic Medicine, Vol. 5, Iss. 5, 2013-01 ,pp. : 1389-1392

Spandidos Publications

Access to resources Recommend Favorite

Time patterns of changes in biomarkers, symptoms and histopathology during pelvic radiotherapy

By Larsen Annette   Bjørge Benedikte   Klementsen Beate   Helgeland Lars   Wentzel-Larsen Tore   Fagerhol Magne K.   Hovdenak Nils   Dahl Olav  

Acta Oncologica, Vol. 46, Iss. 5, 2007-01 ,pp. : 639-650

Informa Healthcare

Access to resources Recommend Favorite